Shopping Cart 0
Cart Subtotal
USD 0

MediPoint: Viscosupplementation-Asia-Pacific Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000

Details

MediPoint: Viscosupplementation-Asia-Pacific Analysis and Market Forecasts

Summary

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the APAC market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the APAC viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Table Of Content

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.1.3 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Viscosupplementation Market 8

3.4 Viscosupplementation Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 14

6 Market Insights 15

6.1 APAC 15

6.1.1 Australia and New Zealand 15

6.1.2 China and Taiwan 16

6.1.3 India 16

6.1.4 Japan 17

6.1.5 South Korea 18

7 Competitive Assessment 19

7.1 Overview 19

7.2 Chugai Pharmaceutical 19

7.2.1 Overview 19

7.2.2 Portfolio Assessment 20

7.2.3 Competitive Positioning 20

7.3 Ferring Pharmaceuticals 20

7.3.1 Overview 20

7.3.2 Portfolio Assessment 21

7.3.3 Competitive Positioning 21

7.4 Sanofi 21

7.4.1 Overview 21

7.4.2 Portfolio Assessment 22

7.4.3 Competitive Positioning 22

7.5 Seikagaku Corporation 22

7.5.1 Overview 22

7.5.2 Portfolio Assessment 23

7.5.3 Competitive Positioning 23

7.6 Other Players 24

8 Appendix 26

8.1 Bibliography 26

8.2 Abbreviations 26

8.3 Methodology 27

8.3.1 Overview 27

8.3.2 Coverage 27

8.3.3 Secondary Research 27

8.3.4 Forecasting Methodology 28

8.3.5 Primary Research Summary 29

8.4 About MediPoint 30

8.5 About GlobalData 30

8.6 Contact Us 30

8.7 Disclaimer 31


List Of Figure

List of Figures

Figure 1: Viscosupplementation Sales for APAC, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Viscosupplementation Market 6

Table 2: APAC Viscosupplementation Volume Forecast, 2014-2023 11

Table 3: APAC Viscosupplementation Average Selling Price Forecast ($), 2014-2023 12

Table 4: APAC Viscosupplementation Market Revenue Forecast ($M), 2014-2023 13

Table 5: APAC Viscosupplementation Company Share Analysis, 2016 14

Table 6: Chugai Pharmaceutical-Key Marketed Products Assessment 20

Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 21

Table 8: Sanofi-Key Marketed Products Assessment 22

Table 9: Seikagaku Corporation-Key Marketed Products Assessment 23

Table 10: Seikagaku Corporation-Key Pipeline Products Assessment 23

Table 11: Summary of Other Players in the Viscosupplementation Market, 2017 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation

Company Profile

Company Profile Title

MediPoint: Viscosupplementation-Asia-Pacific Analysis and Market Forecasts

Summary

Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in Asia-Pacific (APAC: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the APAC market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?

Scope

Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the APAC viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.1.3 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Viscosupplementation Market 8

3.4 Viscosupplementation Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 14

6 Market Insights 15

6.1 APAC 15

6.1.1 Australia and New Zealand 15

6.1.2 China and Taiwan 16

6.1.3 India 16

6.1.4 Japan 17

6.1.5 South Korea 18

7 Competitive Assessment 19

7.1 Overview 19

7.2 Chugai Pharmaceutical 19

7.2.1 Overview 19

7.2.2 Portfolio Assessment 20

7.2.3 Competitive Positioning 20

7.3 Ferring Pharmaceuticals 20

7.3.1 Overview 20

7.3.2 Portfolio Assessment 21

7.3.3 Competitive Positioning 21

7.4 Sanofi 21

7.4.1 Overview 21

7.4.2 Portfolio Assessment 22

7.4.3 Competitive Positioning 22

7.5 Seikagaku Corporation 22

7.5.1 Overview 22

7.5.2 Portfolio Assessment 23

7.5.3 Competitive Positioning 23

7.6 Other Players 24

8 Appendix 26

8.1 Bibliography 26

8.2 Abbreviations 26

8.3 Methodology 27

8.3.1 Overview 27

8.3.2 Coverage 27

8.3.3 Secondary Research 27

8.3.4 Forecasting Methodology 28

8.3.5 Primary Research Summary 29

8.4 About MediPoint 30

8.5 About GlobalData 30

8.6 Contact Us 30

8.7 Disclaimer 31


List Of Figure

List of Figures

Figure 1: Viscosupplementation Sales for APAC, by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Viscosupplementation Market 6

Table 2: APAC Viscosupplementation Volume Forecast, 2014-2023 11

Table 3: APAC Viscosupplementation Average Selling Price Forecast ($), 2014-2023 12

Table 4: APAC Viscosupplementation Market Revenue Forecast ($M), 2014-2023 13

Table 5: APAC Viscosupplementation Company Share Analysis, 2016 14

Table 6: Chugai Pharmaceutical-Key Marketed Products Assessment 20

Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 21

Table 8: Sanofi-Key Marketed Products Assessment 22

Table 9: Seikagaku Corporation-Key Marketed Products Assessment 23

Table 10: Seikagaku Corporation-Key Pipeline Products Assessment 23

Table 11: Summary of Other Players in the Viscosupplementation Market, 2017 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation